The report presents a comprehensive analysis of the Polish commercial clinical trials market from a global perspective, comparing Poland with key international markets.
It also includes an analysis of the potential for further development of the commercial clinical trials market in Poland, as well as the main barriers that may hinder its continued growth.
The authors of the report have also developed recommendations for Poland regarding legislative and institutional changes, based on an analysis of best practices used by countries with a strong position in the commercial clinical trials market.
